A rare-disease federal incentive program critical to biotech R&D is in jeopardy, writes Leslie Williams, president and CEO of ...
European equities traded in the US as American depositary receipts were falling on Friday morning, down 1.5% to 1,436.90 on the S&P Europe Select ADR Index. From continental Europe, the gainers were ...
Shares of Summit Therapeutics, whose cancer drug candidate turned heads after it outperformed a blockbuster drug from Merck, ...
The China fight is on. Last week, the House of Representatives stepped up to the Herculean task of passing 25 bills targeting ...
The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...
The interest rate cut expected this week has a potential double impact of opening financial options to emerging growth ...
Lawmakers took up more than two dozen mostly Republican-led measures aimed at countering Beijing’s technological, political ...